Quick Takeaways
- Bain Capital Life Sciences Opportunities IV, L.P. filed SCHEDULE 13G/A for OLEMA PHARMACEUTICALS, INC. Common Stock, $0.0001 par value per share (OLMA).
- Disclosed ownership: 10%.
- Date of event: 31 Dec 2025.
Bain Capital Life Sciences Opportunities IV, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for OLEMA PHARMACEUTICALS, INC. Common Stock, $0.0001 par value per share (OLMA)
- Filing Manager
- Bain Capital Life Sciences Opportunities IV, L.P.
- Reporting Manager
- Bain Capital Life Sciences Opportunities IV, L.P.
- Symbol
- OLMA
- Shares outstanding
- 85,171,582 shares
- Disclosed Ownership
- 8,508,641 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:30:03 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Bain Capital Life Sciences Opportunities IV, L.P. disclosed 10% ownership in OLEMA PHARMACEUTICALS, INC. Common Stock, $0.0001 par value per share (OLMA) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 15 May 2025.
- Current filing was accepted on 17 Feb 2026, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Opportunities IV, L.P. | 10% | 8,508,641 | 0 | 8,508,641 | /s/ Andrew Hack | Andrew Hack, Partner of Bain Capital Life Sciences Investors, LLC |